FFA
MED icon

Farther Finance Advisors’s Medifast MED Stock Holding History

Farther Finance Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$403 Sell
35
-19
-35% -$217 ﹤0.01% 5787
2026
Q2 		$573 Buy
54
+11
+26% +$127 ﹤0.01% 5507
2026
Q1 		$434 Buy
+43
New +$464 ﹤0.01% 5301
2025
Q4 		– Sell
-64
Closed -$875 – 5539
2025
Q3 		$875 Buy
+64
New +$894 ﹤0.01% 4406
2025
Q1 		– Sell
-4
Closed -$70 – 4356
2024
Q4 		$70 Hold
4
– – ﹤0.01% 3838
2024
Q3 		$77 Sell
4
-40
-91% -$771 ﹤0.01% 3819
2024
Q2 		$925 Buy
44
+36
+450% +$960 ﹤0.01% 3104
2024
Q1 		$300 Sell
8
-6
-43% -$291 ﹤0.01% 3168
2023
Q4 		$941 Sell
14
-9
-39% -$627 ﹤0.01% 2764
2023
Q3 		$1.72K Buy
23
+4
+21% +$355 ﹤0.01% 1912
2023
Q2 		$1.75K Hold
19
– – ﹤0.01% 1800
2023
Q1 		$1.97K Hold
19
– – ﹤0.01% 1654
2022
Q4 		$2.19K Buy
+19
New +$2.21K ﹤0.01% 1420

Other funds holding MED

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MAFA
MJT & Associates Financial Advisory Monteviceo, Minnesota $155M AUM 15.7% 1-Year Est. Return

Farther Finance Advisors's MED Position: Q3 2026 in Review

Farther Finance Advisors reduced its Medifast (MED) stake by 35% in Q3 2026, selling an estimated $217 and leaving 35 shares worth $403. The position accounts for ﹤0.01% of the portfolio, ranked #5787.

Farther Finance Advisors first reported a position in MED in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.19K in Q4 2022. 4 funds tracked by Wall St. Rank hold MED as of Q3 2026.

  • Farther Finance Advisors held 35 shares of Medifast worth $403 as of Q3 2026.
  • Farther Finance Advisors sold 19 Medifast shares in Q3 2026, an estimated $217.
  • Medifast made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5787 holding.
  • Farther Finance Advisors first reported a position in Medifast in Q4 2022 and has held it in 13 quarters since.
  • Farther Finance Advisors's Medifast position peaked at $2.19K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.